Calò G - Search Results

1

Synthesis and Structure-Activity Relationships of (-)-cis-N-Normetazocine-Based LP1 Derivatives.

Pasquinucci L, Parenti C, Amata E, Georgoussi Z, Pallaki P, Camarda V, Calò G, Arena E, Montenegro L, Turnaturi R. Pasquinucci L, et al. Among authors: calo g. Pharmaceuticals (Basel). 2018 May 5;11(2):40. doi: 10.3390/ph11020040. Pharmaceuticals (Basel). 2018. PMID: 29734749 Free PMC article.

2

[Arg(14),Lys(15)]nociceptin, a highly potent agonist of the nociceptin/orphanin FQ receptor: in vitro and in vivo studies.

Rizzi D, Rizzi A, Bigoni R, Camarda V, Marzola G, Guerrini R, De Risi C, Regoli D, Calo' G. Rizzi D, et al. Among authors: calo g. J Pharmacol Exp Ther. 2002 Jan;300(1):57-63. doi: 10.1124/jpet.300.1.57. J Pharmacol Exp Ther. 2002. PMID: 11752097

3

Effects of human urotensin II in isolated vessels of various species; comparison with other vasoactive agents.

Camarda V, Rizzi A, Calò G, Gendron G, Perron SI, Kostenis E, Zamboni P, Mascoli F, Regoli D. Camarda V, et al. Among authors: calo g. Naunyn Schmiedebergs Arch Pharmacol. 2002 Feb;365(2):141-9. doi: 10.1007/s00210-001-0503-0. Epub 2001 Nov 20. Naunyn Schmiedebergs Arch Pharmacol. 2002. PMID: 11819032

4

Pharmacological characterisation of novel kinin B2 receptor ligands.

Camarda V, Rizzi A, Calo G, Wirth K, Regoli D. Camarda V, et al. Among authors: calo g. Can J Physiol Pharmacol. 2002 Apr;80(4):281-6. doi: 10.1139/y02-037. Can J Physiol Pharmacol. 2002. PMID: 12025962

5

Pharmacological profile of hemokinin 1: a novel member of the tachykinin family.

Camarda V, Rizzi A, Calo G, Guerrini R, Salvadori S, Regoli D. Camarda V, et al. Among authors: calo g. Life Sci. 2002 Jun 14;71(4):363-70. doi: 10.1016/s0024-3205(02)01682-x. Life Sci. 2002. PMID: 12044836

6

Pharmacological characterisation of [(pX)Phe4]nociceptin(1-13)amide analogues. 1. In vitro studies.

Bigoni R, Rizzi D, Rizzi A, Camarda V, Guerrini R, Lambert DG, Hashiba E, Berger H, Salvadori S, Regoli D, Calo' G. Bigoni R, et al. Among authors: calo g. Naunyn Schmiedebergs Arch Pharmacol. 2002 Jun;365(6):442-9. doi: 10.1007/s00210-002-0548-8. Epub 2002 Apr 19. Naunyn Schmiedebergs Arch Pharmacol. 2002. PMID: 12070757

7

A new ligand for the urotensin II receptor.

Camarda V, Guerrini R, Kostenis E, Rizzi A, Calò G, Hattenberger A, Zucchini M, Salvadori S, Regoli D. Camarda V, et al. Among authors: calo g. Br J Pharmacol. 2002 Oct;137(3):311-4. doi: 10.1038/sj.bjp.0704895. Br J Pharmacol. 2002. PMID: 12237249 Free PMC article.

8

Urantide mimics urotensin-II induced calcium release in cells expressing recombinant UT receptors.

Camarda V, Song W, Marzola E, Spagnol M, Guerrini R, Salvadori S, Regoli D, Thompson JP, Rowbotham DJ, Behm DJ, Douglas SA, Calo' G, Lambert DG. Camarda V, et al. Among authors: calo g. Eur J Pharmacol. 2004 Sep 13;498(1-3):83-6. doi: 10.1016/j.ejphar.2004.07.089. Eur J Pharmacol. 2004. PMID: 15363979

9

Urotensin II stimulates plasma extravasation in mice via UT receptor activation.

Vergura R, Camarda V, Rizzi A, Spagnol M, Guerrini R, Calo' G, Salvadori S, Regoli D. Vergura R, et al. Among authors: calo g. Naunyn Schmiedebergs Arch Pharmacol. 2004 Nov;370(5):347-52. doi: 10.1007/s00210-004-0991-9. Epub 2004 Oct 23. Naunyn Schmiedebergs Arch Pharmacol. 2004. PMID: 15526105

10

Structure-activity relationship study on human urotensin II.

Guerrini R, Camarda V, Marzola E, Arduin M, Calo G, Spagnol M, Rizzi A, Salvadori S, Regoli D. Guerrini R, et al. Among authors: calo g. J Pept Sci. 2005 Feb;11(2):85-90. doi: 10.1002/psc.590. J Pept Sci. 2005. PMID: 15635628

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

398 results

Search Page